Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Arcus Biosciences, Inc. RCUS

Set alert

Price alert · RCUS

All alert types
18.78 USD +0.93 +5.23%

As of Nov 3, 3:12 PM ET

Bid
18.77 × 100
Ask
18.79 × 200
18.05 Day range 18.98
17.76 52-week range 31.57
YTD
-21.17%
1 year
-7.69%
Open
18.12
Prev close
17.85
Mkt cap
2.36B
Vol
975.31K
Avg vol
1.82M
EPS
-3.91
P/E
0.00
Div yield
0.00%
More statistics
Low
18.05
High
18.98
Forward P/E
-5.72
Beta
1.09
Short ratio
8.16
Inst. own
66.27%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
24.98
200-d avg
24.67
1y target
41.00

1M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 14, 2026Rating: JP Morgan · — → Overweight
  • Oct 16, 2026Rating: William Blair · — → Outperform
  • Oct 21, 2026Rating: Wedbush · Outperform → Outperform
  • Oct 21, 2026Rating: Truist Securities · Buy → Buy
  • Oct 21, 2026Rating: Citigroup · Buy → Buy
Signals (8)
NameDateAgo
SMA: BullishNov 3, 20265 hours ago
RSI: OversoldNov 2, 20261 day ago
SMA: BearishOct 21, 20261 week ago
RSI: OversoldOct 21, 20261 week ago
SMA: BullishOct 20, 20262 weeks ago
MACD: Sell SignalOct 13, 20263 weeks ago
MACD: Buy SignalOct 12, 20263 weeks ago
MACD: Sell SignalOct 6, 20264 weeks ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 41.00 +118.3% upside
Target (low)
23.00
Target (mean)
41.00
Target (high)
50.00
Ratings (0m) 15 13 buy · 2 hold · 0 sell
  • Strong buy1
  • Buy12
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 15
  • 1 month ago 13
  • 2 months ago 13

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

RCUS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.89254-1.00 – -0.84-1.27+29.7%8.27M-68.2%9
Next quarter-0.84183-0.96 – -0.75-0.89+5.4%5.99M-81.8%9
Current year-3.52-4.35 – -3.10-3.29-6.9%73.15M-70.4%9
Next year-3.12-4.50 – -2.16-3.52+11.2%56.52M-22.7%9

Upgrades and downgrades

The latest rating changes

RCUS analyst upgrades and downgrades
DateFirmActionFromTo
Oct 21, 2026CitigroupMaintainedBuyBuy
Oct 21, 2026Truist SecuritiesMaintainedBuyBuy
Oct 21, 2026WedbushMaintainedOutperformOutperform
Oct 16, 2026William BlairInitiated—Outperform
Oct 14, 2026JP MorganInitiated—Overweight
Sep 30, 2026WedbushReiteratedOutperformOutperform
Sep 16, 2026TD CowenInitiated—Buy
Sep 8, 2026Truist SecuritiesReiteratedBuyBuy
Aug 6, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Aug 6, 2026WedbushMaintainedOutperformOutperform
Jul 20, 2026HC Wainwright & Co.MaintainedBuyBuy
Jun 4, 2026LifeSci CapitalInitiated—Outperform
May 11, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
May 7, 2026Goldman SachsMaintainedBuyBuy
Apr 2, 2026WedbushMaintainedOutperformOutperform
Mar 5, 2026CitigroupMaintainedBuyBuy
Mar 2, 2026Leerink PartnersMaintainedOutperformOutperform
Mar 2, 2026HC Wainwright & Co.ReiteratedBuyBuy
Feb 12, 2026Wells FargoDowngradeOverweightEqual-Weight
Jan 13, 2026Goldman SachsUpgradeNeutralBuy
Jan 8, 2026Morgan StanleyDowngradeOverweightEqual-Weight
Dec 12, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 28, 2025B of A SecuritiesMaintainedNeutralNeutral
Oct 30, 2025Goldman SachsMaintainedNeutralNeutral
Oct 29, 2025CitigroupMaintainedBuyBuy
Oct 29, 2025HC Wainwright & Co.MaintainedBuyBuy
Oct 20, 2025Wells FargoMaintainedOverweightOverweight
Oct 13, 2025CitigroupMaintainedBuyBuy
Oct 7, 2025Truist SecuritiesReiteratedBuyBuy
Aug 7, 2025Morgan StanleyMaintainedOverweightOverweight